Results 151 to 160 of about 8,117 (271)

Reply to Lipworth et al. [PDF]

open access: yes, 2020
We thank Dr. Lipworth and colleagues for their interest in our work published recently in the Journal (1). They rightly point out that the biology of asthma attacks is more complex than blood eosinophils alone and that corticosteroids have a wide range ...
Borg, Catherine A.   +8 more
core   +1 more source

Bronchial thermoplasty: implementing best practice in the era of cost containment. [PDF]

open access: yes, 2017
Increasing dependence on advanced technologies in the 21st century has created a dilemma between the practice and business of medicine. From information technology to robotic surgery, new technologies have expanded treatment possibilities and have ...
Kenyon, Nicholas   +3 more
core  

Efficacy of benralizumab in severe eosinophilic asthma: results of a real clinical practice prospective study BEST in Russia

open access: yesPULMONOLOGIYA
The study of the efficacy of biological therapy in patients with severe bronchial asthma in real world settings is a relevant task since observational research programs allow answering questions that fall out of focus with a strict selection of patients ...
D. Fomina   +9 more
semanticscholar   +1 more source

Eosinophilic granulomatosis with polyangiitis developed during treatment with benralizmab for severe asthma: A case report and literature review

open access: yesRespirology Case Reports
Eosinophilic granulomatosis with polyangiitis (EGPA) is a rare autoimmune disorder characterized by necrotizing vasculitis, asthma, and eosinophilia. We report a case of EGPA that developed during benralizumab treatment for severe asthma and provide a ...
Mitsukuni Sakabe   +5 more
doaj   +1 more source

Efectividad de mepolizumab y benralizumab en una cohorte de pacientes con asma grave eosinofílico en vida real

open access: yesOpen Respiratory Archives, 2021
Resumen: Introducción: El mepolizumab es un anticuerpo monoclonal que bloquea la interleuquina 5 circulante (IL5). El benralizumab se une a la subunidad alfa del receptor de la IL 5 induciendo la eliminación directa de eosinófilos y basófilos.
María José Espinosa de los Monteros Garde   +2 more
doaj  

A Case of Allergic Bronchopulmonary Aspergillosis With Failure of Benralizumab and Response to Dupilumab [PDF]

open access: gold, 2023
Yasuaki Kotetsu   +4 more
openalex   +1 more source

Asthma Clinical Remission with Benralizumab in an Integrated Analysis of the Real-World XALOC-1 Study [PDF]

open access: bronze, 2023
D.A. Jackson   +15 more
openalex   +1 more source

Resolution of Chronic Eosinophilic Pneumonia during Treatment with Benralizumab in Patient with Peripheric Blood Eosinophilia

open access: gold, 2021
Alessandra Giuliano   +14 more
openalex   +1 more source

Home - About - Disclaimer - Privacy